과학
중도 성향
Branded Bevacizumab Approved for Wet AMD
MedPage Today
(MedPage Today) -- The FDA approved the first formulation of bevacizumab specifically for the treatment of neovascular (wet) age-related macular degeneration (nAMD), Outlook Therapeutics announced on Friday.
The approval of bevacizumab-vikg (Lytenava...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요
관련 뉴스
관련 뉴스 제보는 로그인 후 가능합니다.
'science' 카테고리 뉴스
Prize honors discovery of altermagnetism as a third fundamental class of magnetism
Phys.org
Rates of opioid toxicity deaths highest among construction and trades workers, study finds
Medical Xpress
SpaceX's Starship megarocket makes the 'softest splashdown' ever after launching next-gen Starlink satellites in Flight 13 test (video)
Space.com